Integration of intellectual property and regulatory exclusivity strategies for life science companies

In a new podcast, my colleagues Ray Miller and Nicole Endejann, along with Tom Petzinger of Knopp Neurosciences Inc., discuss intellectual property and regulatory exclusivity strategies necessary for emerging life science companies to secure investments, strategic partnerships or licenses with third parties. 

To download the podcast or listen to the podcast online, click here.

One response to “Integration of intellectual property and regulatory exclusivity strategies for life science companies

  1. Good timing. What with so many biotech and similar companies now facing the dreaded “patent cliff,” this is the moment to start shoring up their assets, if they haven’t done so already.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s